Metraipolis › archive › dc_9bf86896a7ea

Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer — Europe PMC PMID:41521275

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41521275
DOI
10.1002/cam4.71475
License (as archived)
solo-consultazione
Archived
2026-10-07T17:43:34.487Z
SHA-256 of the archived text
696592d5462bcd8d1489a04c0869f84eb9b1c5c991259bf5ea89ffc3b55699b4
Stable URL of this page
https://metraipolis.com/documento/dc_9bf86896a7ea

How to cite

Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer — Europe PMC PMID:41521275 — Europe PMC (en), https://europepmc.org/article/MED/41521275 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9bf86896a7ea (Metraipolis archive dc_9bf86896a7ea, sha256 696592d5462bcd8d1489a04c0869f84eb9b1c5c991259bf5ea89ffc3b55699b4)
BibTeX
@misc{dc9bf86896a7ea,
  title = {Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer — Europe PMC PMID:41521275},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41521275},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9bf86896a7ea; sha256 696592d5462bcd8d1489a04c0869f84eb9b1c5c991259bf5ea89ffc3b55699b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41521275. Agents can read the archived copy with the MCP tool read_document.